Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Ascherio

Munger

Lunemann

. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602–612.

Cohen

. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481–492.

Pakpoor

Disanto

Gerber

. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: A meta-analysis. Mult Scler 2013; 19: 162–166.

Owens

Bennett

. Trigger, pathogen, or bystander: The complex nexus linking Epstein-Barr virus and multiple sclerosis. Mult Scler 2012; 18: 1204–1208.

Sundqvist

Sundstrom

Linden

. Epstein-Barr virus and multiple sclerosis: Interaction with HLA. Genes Immun 2012; 13: 14–20.

Sargsyan

Shearer

Ritchie

. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010; 74: 1127–1135.

Lassmann

Niedobitek

Aloisi

. Epstein-Barr virus in the multiple sclerosis brain: A controversial issue – report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011; 134: 2772–2786.

Luzuriaga

Sullivan

. Infectious mononucleosis. N Engl J Med 2010; 362: 1993–2000.

Fleming

Cook

. Multiple sclerosis and the hygiene hypothesis. Neurology 2006; 67: 2085–2086.

10.

Zaadstra

Chorus

van Buuren

. Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler 2008; 14: 307–313.

Epstein–Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No

Abstract

Get full access to this article

References